ArticleBioengineering & translational medicine2023
An ultralow power wearable vital sign sensor using an electromagnetically reactive near field.
Article in Bioengineering & translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An ultralow power wearable vital sign sensor using an electromagnetically reactive near field.Bioengineering & translational medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite coronavirus disease 2019, cardiovascular disease, the leading cause of global death, requires timely detection and treatment for a high survival rate, underscoring the 24 h monitoring of vital signs. Therefore, telehealth using wearable devices with vital sign sensors is not only a fundamental response against the pandemic but a solution to provide prompt healthcare for the patients in remote sites. Former technologies which measured a couple of vital signs had features that disturbed practical applications to wearable devices, such as heavy power consumption. Here, we suggest an ultralow power (100 μW) sensor that collects all cardiopulmonary vital signs, including blood pressure, heart rate, and the respiration signal. The small and lightweight (2 g) sensor designed to be easily embedded in the flexible wristband generates an electromagnetically reactive near field to monitor the contraction and relaxation of the radial artery. The proposed ultralow power sensor measuring noninvasively continuous and accurate cardiopulmonary vital signs at once will be one of the most promising sensors for wearable devices to bring telehealth to our lives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.